Earnings Releases·Nov 12, 2026, 4:10 PM ET

United States Antimony Corporation — Third Quarter 2026 Earnings Summary

Q3 2026 revenue rose 16% year-over-year to $10.1 million with gross margin expanding to 42% from 23%, though net loss widened to $9.5 million from $4.8 million due to a $3.8 million unrealized loss on the Larvotto investment.
The company shifted to volume-based guidance for full-year 2026 antimony sales (1.68–1.81 million pounds, up ~24%) and withdrew prior revenue guidance, while securing $57.3 million in DLA delivery orders with cycle times improving to ~70 days.
Strategic operational milestones included the Q3 start-up of the Radersburg processing plant, the publication of a Technical Report for the Nolan Creek project, and the commencement of bulk sampling at the Fostung tungsten project.
Capital allocation included $28.4 million in capital expenditures for the first nine months of 2026 and a $100 million share repurchase program, of which $3.1 million was utilized in Q3 and October 2026.
Liquidity remains strong with $51.0 million in cash and Treasuries and no outstanding borrowings on the $19.0 million credit line, supporting continued expansion despite a 34% decline in average antimony prices.